DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Endroit courant :
>
> This Story


Ouverture ou Registre to rate this News Story
Forward Printable StoryPrint Comment

 

 

Molecular Imaging Homepage

MGH team develops a potential alternative to gadolinium-based contrast agents Made of the vital element manganese

Global PET/CT scanner market projected to reach $2.1 billion by 2023 Growth spurred in part by increased Medicare coverage

Can theranostics be the key to completely curing colorectal cancer? Preclinical trials yield promising results

Cerveau Technologies to collaborate in development of PET imaging agents for Alzheimer’s disease

MJFF and Tau Consortium partner to accelerate the development of new PET tracers May detect early stage neurodegenerative disease

Cerveau inks deal with AbbVie for investigational tau imaging PET agent Stage III clinical trial to begin in next few months

New molecular imaging technology for prostate cancer may improve surgical outcomes Lightpoint Medical forges new partnerships

New imaging system may accelerate drug development for Alzheimer's cryo-MOST provides more detail than MR and PET

Phase I trial demonstrates safe use of radiotracer produced in minutes Manufactured using a Ga-68 generator and a cold kit vial

Bracco Imaging acquires SurgVision Enables development of a real-time fluorescence image-guided surgery platform

GE Healthcare's Omniscan
Gadolinium-based contrast media

Courtesy of Wikimedia

Researchers develop method that generates multi-color MR images

par Lauren Dubinsky , Senior Reporter
Researchers at Case Western Reserve University School of Medicine found out how to make MR images multicolor.

They did that by developing a new method that uses two contrast agents at once. This allows physicians to map multiple characteristics of a patient's internal organs from a single MR exam.

Story Continues Below Advertisement

CT, MRI, NM, SPECT/CT, PET & PET/CT service, refurbished systems and parts

Accelerate your ROI with our Black Diamond Certified refurbished systems. One year warranty - ISO 13485 Certified - FDA registered - Over 65k parts in inventory



"The multicolored term is used here to [explain] that this new MRI technique is analogous to simultaneous detection of two optical imaging agents that use different fluorophores (e.g., red and green)," Chris Flask, associate professor at the university, told HCB News.

He believes that this multi-agent detection capability has the potential to transform molecular imaging because it provides a translation pathway for studies in patients. It also provides a unique imaging platform to rigorously study molecular therapies that target biomarkers or other detectable molecules associated with certain diseases.

In addition to a research tool, this method could also be used to diagnose. One of the contrast agents could specifically target the diseased tissue and the other could be designed to show healthy tissue.

Flask and his team recently published a paper that discussed their new method in Scientific Reports. They used gadolinium and manganese, which can be detected and independently quantified during MR exams.

The team stated that their results provide "an adaptable, quantitative imaging framework to assess two MR contrast agents simultaneously for a wide variety of imaging applications."

They have already started to investigate potential applications for the new method. Those may include studies in cancers, genetic diseases like cystic fibrosis, and metabolic diseases such as diabetes.

Flask noted that both combinations of two FDA-approved agents, as well as new molecular MR contrast agents, will need to be evaluated for safety and benefits to patient populations.

"However, this new MR technology opens the door to considering those combinations of agents that will be first evaluated in basic science studies, and then eventually in patients," he added.

Molecular Imaging Homepage


You Must Be Logged In To Post A Comment

Publicité
Développez la notoriété de votre marque
Enchères + Ventes Privées
Obtenir le meilleur prix
Acheter des équipement / pièces
Trouver le meilleur prix
Infos du jour
Lire Les dernières nouvelles
Annuaire
Consulter tous les utilisateurs DOTmed
Éthique concernant DOTmed
Voir notre programme d'éthique
L'or partie le programme de fournisseur
Recevoir des demandes PH
Programme de marchand de service d'or
Recevoir des demandes
Fournisseurs de soins de santé
Voir tous les outils des HCP (abréviation pour les professionnels de la santé)
Les travaux/Formation
Trouver / combler un poste
Parts Hunter +EasyPay
Obtenir des devis de pièces
Certification Récentes
Voir les utilisateurs récemment certifiés
Evaluation Récentes
Voir les utilisateurs récemment certifiés
Central de location
Louer de l’équipement à moindre prix
Vendre des équipements / pièces
Obtenir le maximum d'argent
Service le forum de techniciens
Trouver de l'aide et des conseils
Simple demande de propositions
Obtenir des devis pour des appareils
Expo Virtuelle
Trouver des services d'appareils
L'Access et l'utilisation de cet emplacement est sujet aux modalités et aux conditions du notre de nos MENTIONS LEGALES & DONNEES PERSONELLES
Propriété de et classe des propriétaires DOTmedà .com, inc. Copyright ©2001-2017 DOTmed.com, Inc.
TOUS DROITS RÉSERVÉS